Obesity and Cancer

dc.contributor.authorKumar, Shashank
dc.contributor.authorGupta, Sanjay
dc.date.accessioned2024-01-16T14:23:09Z
dc.date.accessioned2024-08-13T10:34:07Z
dc.date.available2024-01-16T14:23:09Z
dc.date.available2024-08-13T10:34:07Z
dc.date.issued2021-07-18T00:00:00
dc.description.abstractThis book highlights the concordance between signaling pathways that are involved in obesity and cancer cross-talks. It describes the role of cytokines, chemokines, growth factors, insulin, and adipokines in the development of obesity-associated cancers. The book reviews the role of inflammatory signaling pathways such as estrogen-mediated signaling, mTOR and AMP-activated protein kinase pathway and the involvement of adaptive and innate immunity, oxidative stress, gene polymorphism, dietary phytochemicals, and miRNAs in obesity and cancer. In addition, it covers the latest research on the drugs and natural therapeutic agents that target obesity-induced cancers and discusses various in vivo models for studying obesity and obesity-associated cancer. Lastly, it analyses the role of genetic polymorphisms in the obesity-related genes that influence cancer development. The book is a useful resource for researchers in the field of cancer, pharmacology, food chemistry, and clinical biochemistry. � The Editor(s) (if applicable) and The Author(s), under exclusive license to Taylor and Francis Pte Ltd. 2021.en_US
dc.identifier.doi10.1007/978-981-16-1846-8
dc.identifier.isbn9789811618468
dc.identifier.isbn9789811618451
dc.identifier.urihttps://doi.org/10.1007/978-981-16-1846-8
dc.identifier.urihttps://kr.cup.edu.in/handle/32116/2855
dc.language.isoen_USen_US
dc.publisherSpringer Singaporeen_US
dc.subjectCanceren_US
dc.subjectmiRNAen_US
dc.subjectObesityen_US
dc.subjectPhytochemicalsen_US
dc.subjectSignaling pathwaysen_US
dc.titleObesity and Canceren_US
dc.title.journalObesity and Canceren_US
dc.typeBooken_US
dc.type.accesstypeOpen Accessen_US

Files